<div id="readability-page-1"><div><p>Potential <strong>Profound Medical Corp.</strong> (TSE:PRN) shareholders may wish to note that the Independent Director, Arthur L. Rosenthal, recently bought CA$139k worth of stock, paying CA$10.01 for each share.    That's a very solid buy in our book, and increased their holding by a noteworthy 31%.</p> <p>We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.</p><h2> The Last 12 Months Of Insider Transactions At Profound Medical </h2> <p> Over the last year, we can see that the biggest insider purchase was by Chairman of the Board &amp; CEO Arun Menawat for CA$144k worth of shares, at about CA$10.16 per share.    That means that an insider was happy to buy shares at around the current price of CA$10.25.  While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future.  While we always like to see insider buying, it's less meaningful if the purchases were made at much lower prices, as the opportunity they saw may have passed.   The good news for Profound Medical share holders is that insiders were buying at near the current price.     </p> <p> In the last twelve months Profound Medical insiders were buying shares, but not selling.    They paid about CA$7.97 on average.    To my mind it is good that insiders have invested their own money in the company.  However, you should keep in mind that they bought when the share price was meaningfully below today's levels.      You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below.  By clicking on the graph below, you can see the precise details of each insider transaction! </p><p><span> See our latest analysis for Profound Medical </span></p><figure><img height="872" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/108191898-insider-trading-volume-1-dark-2/1766658457196?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="1642" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/108191898-insider-trading-volume-1-dark-2/1766658457196"/><figcaption>TSX:PRN Insider Trading Volume December 25th 2025</figcaption></figure><p> There are always plenty of stocks that insiders are buying. If investing in lesser known companies is your style, you could take a look at this <strong>free</strong> list of companies. (Hint: insiders have been buying them). </p> <h2> Does Profound Medical Boast High Insider Ownership? </h2><p> For a common shareholder, it is worth checking how many shares are held by company insiders.  I reckon it's a good sign if insiders own a significant number of shares in the company.   Profound Medical insiders own about CA$15m worth of shares. That equates to 4.7% of the company.  We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.  </p><h2> So What Does This Data Suggest About Profound Medical Insiders? </h2><p> It's certainly positive to see the recent insider purchases.    And the longer term insider transactions also give us confidence.   However, we note that the company didn't make a profit over the last twelve months, which makes us cautious.    Given that insiders also own a fair bit of Profound Medical we think they are probably pretty confident of a bright future.      Therefore, you should definitely take a look at this <strong>FREE</strong> report showing analyst forecasts for Profound Medical. </p><p> Of course, <strong>you might find a fantastic investment by looking elsewhere.</strong> So take a peek at this <strong>free</strong> list of interesting companies. </p><p><em>For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.</em></p><div><p>Mobile Infrastructure for Defense and Disaster</p><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p><p>Get the investor briefing before the next round of contracts</p><p><span>Sponsored On Behalf of CiTech</span></p></div></div></div>

PROF

<p>Arthur L. Rosenthal, Independent Director of Profound Medical Corp., recently purchased CA$139k worth of stock at CA$10.01 per share, increasing his holding by 31%. Over the past year, insiders, including Chairman & CEO Arun Menawat, have been buying shares at prices close to the current level, indicating confidence in the company's future. Insiders own about CA$15m worth of shares, representing 4.7% of the company.</p>

Independent Director of Profound Medical Picks Up 31% More Stock